A18-00/ENGOT-CX11
Trial Description:
A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer
Lead Cooperative Group:
Trial Number:
Disease Site:
Cervical
Trial Status:
Recruiting
Contact person:
dlorusso